Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Pfizer to acquire Idun Pharmaceuticals in cash transaction

Executive Summary

Pfizer has agreed to buy Idun Pharmaceuticals (therapeutics to control apoptosis) for, according to one of Idun's investors, approximately $280mm in cash.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Acquisition of Private Biotech

Related Companies

Advertisement
UsernamePublicRestriction

Register